To compare the efficacy of mesalazine and salazepyridine in the treatment of children with mild to moderate ulcerative colitis (UC).
A total of 80 children with mild to moderate UC admitted to our hospital from April 2021 to February 2023 were selected and divided into control group and observation group by simple sorting, with 40 cases in each group. The control group received salazepyridine treatment, and the observation group received mesalazine treatment, the course of treatment was 2 months. The clinical efficacy and the changes of intestinal flora, serum D-lactic acid (LAC), perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA), the levels of diamine oxidase (DAO), endotoxins (ET), interleukin (IL)-1β, IL-6 and IL-23 before and after treatment were compared between the two groups, and adverse reactions during treatment and disease recurrence at 12 months of follow-up were recorded.
After treatment, the clinical effect of observation group was better than that of control group (P<0.05). Serum levels of D-LAC, P-ANCA, DAO, ET, IL-1β, IL-6 and IL-23 in observation group were lower than those in control group (P<0.05). Enterococcus, Saccharomycetes and Enterobacter were lower than those in control group (P<0.05), Lactobacillus, Bifidobacterium and Bacteroides were higher than those in control group (P<0.05). The number of adverse reactions in control group was higher than that in observation group, but there was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). After 12 months of follow-up, there was no significant difference in UC recurrence between the two groups (P>0.05).
Both mesalazine and salazepyridine can be used in the treatment of children with mild to moderate UC. Compared with salazepyridine, mesalazine has more advantages in efficacy, reducing serum D-LAC and p-ANCA expression, regulating intestinal flora, inhibiting inflammatory response, and improving intestinal barrier function, with better safety.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |